login

Management of Professionals: Insights for Maximizing Cooperation

Bulletin of the Medical Library AssociationPublished 1 January 1989
Sue Stigleman
Citations4

TL;DR

Anti-TNF therapy does not increase Crohn’s perianal fistula closure rates in patients with stem cell transplantation, however, both refractory and non-refractory CPF have similar closure rates after additional anti-TNF therapy.

Abstract

Anti-TNF therapy does not increase CPF closure rates in patients with stem cell transplantation. However, both refractory and non-refractory CPF have similar closure rates after additional anti-TNF therapy. Fistulous tract length, proctitis, and anal stricture are risk factors for non-closure in patients with CPF after stem cell transplantation.

Keywords

Business, Management and Accounting